Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Liraglutide for Sale > TNJONE High Quality 99% Purity China Supply 99% Purity Liraglutide Raw Material Powder
TNJONE High Quality 99% Purity China Supply 99% Purity Liraglutide Raw Material Powder buy - large image1
TNJONE High Quality 99% Purity China Supply 99% Purity Liraglutide Raw Material Powder buy - image1
TNJONE High Quality 99% Purity China Supply 99% Purity Liraglutide Raw Material Powder buy - image2
TNJONE High Quality 99% Purity China Supply 99% Purity Liraglutide Raw Material Powder buy - image3
TNJONE High Quality 99% Purity China Supply 99% Purity Liraglutide Raw Material Powder buy - image4
TNJONE High Quality 99% Purity China Supply 99% Purity Liraglutide Raw Material Powder buy - image5
TNJONE High Quality 99% Purity China Supply 99% Purity Liraglutide Raw Material Powder buy - image6

TNJONE High Quality 99% Purity China Supply 99% Purity Liraglutide Raw Material Powder

24 Inquiries

Unit Price: Get Latest Price
CAS No.:

204656-20-2

Grade:

Top Product

Content:

99%

Port:

china any port

Brand:

TNJONE

Packaging:

10g,25g,50g or according to customer's detail requirement.

Price valid (until):

2025-12-31

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
5 days
Qualification:
Main Products:

Semaglutide,Tirzepatide,API,Vitamins,Food Additive

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    Product Description


    Shop Weight Loss Aurantium Extract Synephrine Hydrochloride Raw Material Synephrine HCl Powder Synephrine Hydrochloride-Detailed Image 1

    Wh at is  Liraglutide ?

    Liraglutide (NN2211) is a long-acting gluca on-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insuli secretion.
    Liraglutide was approved for treatment of type 2 diabetes by the European Medicines Agency (EMA) on July 3, 2009, and by the U.S. Food and Drug Administration (FDA) on January 25, 2010.    More recently, Liraglutide was approved by the FDA on December 23, 2014 for treatment for obesity in adults with some related comorbidity.



    Product Name

    Liraglutide

    Appearance powder
    Molecular formula C172H265N43O51
    Keywords Liraglutide;Glycine,L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-LChemicalbook-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida[inn-spanish];Liraglutide[usan:inn];Liraglutidum;Liraglutidum[inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide
    Shelf Life 24 months when properly stored
    Storage Keep in a cool, dry, dark location



    Function and  Application

    • In common to various degrees with other GLP-1 receptor agonists,liraglutide has advantages over more traditional therapies for type 2 diabetes:
      1.    Liraglutide acts in a glucose-dependent manner, meaning Liraglutide will stimulate insu.   lin secretion only when blood glucose levels are higher than normal, preventing "overshoot".   Consequently, Liraglutide shows negligible risk of hypoglycemia.
      2.    Liraglutide has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies).
      3.    Liraglutide decreases appetite and inhibits body weight gain,as shown in a head-to-head study versus glimepiride.
      4.    Liraglutide lowers blood triglyceride levels.

      Shop Weight Loss Aurantium Extract Synephrine Hydrochloride Raw Material Synephrine HCl Powder Synephrine Hydrochloride-Detailed Image 2


      Company Profile 


    Shop Factory Direct Supply high quality Antibiotic Ceftriaxone sodium Cas104376-79-6-Detailed Image 5

    Shaanxi TNJONE Pharmaceutical Co., Ltd is a high-tech enterprise mainly engaged inthe development and sale of pharmaceutical chemical raw materials and relatedproducts.The company has advanced and perfect supporting system,forming advancedchemical synthesis technology, which can quickly meet the individual needs and serialdevelopment from suitable detection to industrial production.Qur business covers morethan 30 countries, most of customers from Europe, Southeast Asia and other countriesin the world, we can guarantee the quality and price. Our enterprise purpose is basedon the market, strengthen strength, take the road of scientific environmental protectionand sustainable development, rely on the country. The company has a strong financialstrength and a good business environment, can provide customers with quality,efficientand fast service.


       Our Advantages  


    Shop GMP TNJONE  High Purity Pharmaceutical Raw Materials CAS 38821-53-3 Cephradine-Detailed Image 4
    1.High quality and competitive price.

    2.Free sample for your evaluation.
    3.Promptly delivery by well-reputed shipping lines.
    4.Trial order is available for testing after samples.
    5.We will inform you all the information at every stage in advance.
    6.Packaging can gear to buyers' special request. 


     Our factory   


    Shop Factory Direct Supply high quality Antibiotic Ceftriaxone sodium Cas104376-79-6-Detailed Image 8 Shop China Supplier Factory TNJONE Direct Supply high quality CAS 15676-16-1 Sulpiride Pharmaceutical Raw Material-Detailed Image 5

    Shop Factory Direct Supply high quality Antibiotic Ceftriaxone sodium Cas104376-79-6-Detailed Image 9 Shop Factory Direct Supply high quality Antibiotic Ceftriaxone sodium Cas104376-79-6-Detailed Image 10


      Our package  


    Shop High Purity Pharmaceutical API Antibiotic Raw Material Fusidine Powder CAS 6990-06-3-Detailed Image 10

    Shop TNJONE High Quality TNJONE Pharmaceutical Intermediate CAS 376592-93-7 3 -Amino-2 -Hydroxy-Biphenyl-3-Carboxylic Acid-Detailed Image 9



      How to order  



    Before ordering

    Please send what items and what quantity you need
    Send quotation We will send you a quotation in detail with total
    Payment ways chosen Please choose one of the payment way you preferred.
    Our payment ways: City bank,BTC,Bank wire, Wise,Master Card , Tether
    After payment Please offer shipping address after payment for shipment.
    Tracking We will provide the tracking after goods sent.
    Lead time About 1-5 working days after payment
    Shipping time About 8-15 days door to door
    After-sale service Available always


    ECHEMI Editorial Reference
    Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
    Liraglutide is characterized as a white to almost white powder. It is freely soluble in aqueous base solutions (> 270 mg/mL), but its water solubility decreases below pH 7 and reaches its lowest level at pH 4-5 (approximately 0.05 mg/mL). Solubility increases marginally at pH 2.5 where it is very slightly soluble (≤ 0.8 mg/mL). Liraglutide is soluble in methanol (68 mg/mL) and very slightly soluble in ethanol (1.1 mg/mL). The isoelectric point of liraglutide is approximately 4.9. The pH of a 1 mg/mL aqueous solution of drug substance is approximately 9.3.
    ChEBI: Liraglutide, a lipopeptide and polypeptide, is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Liraglutide functions as a glucagon-like peptide-1 receptor agonist and serves as a neuroprotective agent.
    Liraglutide is GLP-1(1–37) modified at Ly: the -amino group is acylated with an (N-hexadecanoyl)glutam- -yl moiety that noncovalently but avidly binds tohuman serum albumin. (Also, Lys is conservatively replacedwith Arg.) These changes provide for a greatly extendedserum t12 of~10 to 15 hours after sc administration(0.6–1.8 mg), allowing for once-daily dosing.Liraglutide (Victoza, Novo Nordisk) is awaiting approvalby the FDA, EMEA, and the Koˉ roˉ -shoˉ (Japan).
    Liraglutide peptide is a single, non-glycosylated polypeptide chain containing 31 amino acids, having a molecular mass of 3751 Dalton and a Molecular formula of C172H265N43O51.

    Basic Info
    Product Name:

    Liraglutide

    Other Name:

    Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide

    CAS No.:

    204656-20-2

    Molecular Formula:

    C172H265N43O51

    InChIKeys:

    YSDQQAXHVYUZIW-VTFFJMQZNA-N

    Molecular Weight:

    3751.202

    Exact Mass:

    3748.95000

    EC Number:

    810-818-7

    Color/Form:

    White to Off-White

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    1513.76000

    XLogP3:

    6.12960

    Melting Point:

    >182°C (dec.)

    Critical Temperature & Pressure:

    Refrigerator

    Research
    Class:

    GLP-1 receptor agonist (acylated GLP-1 analog, 31-amino-acid peptide)

    Status:

    FDA-approved (Victoza 2010, Saxenda 2014 for obesity)

    Mechanism:

    A 31-amino-acid GLP-1 analog with a C16 fatty-acid chain (palmitoyl) attached to Lys26 via a gamma-glutamic acid spacer. This fatty-acid modification enables reversible binding to serum albumin, extending the half-life to ~13 hours. Activates GLP-1R to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite.

    EC50 (GLP1R Ec50):

    ~10 nM

    Source:

    DrugBank: DB06655; Knudsen LB, et al. J Med Chem. 2000;43(9):1664-1669.DOI

    Clinical Development:

    NCT00781922; NCT01272219

    FDA:

    Victoza, Saxenda (approved 2010-01-25)

    References
    ChEMBL:

    CHEMBL1213363

    DrugBank:

    DB06655

    KEGG DRUG:

    D09199

    PubChem:

    PubChem

    Disclaimer:

    Liraglutide is FDA-approved as a prescription medicine (Victoza for T2DM, Saxenda for obesity). This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide,Tirzepatide,API,Vitamins,Food Additive

    Location:

    No. 4C-11-A392, Financial Port, Northwest corner of Fengjing Avenue and Fengxin Road, Fengdong New City, Xi 'an, Shaanxi Province

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    5 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2019

    Shaanxi TNJONE Pharmaceutical Technology Co., LTD., located in the beautiful ancient capital Xi 'an, is committed to the peptide industry, pharmaceutical raw materials, food and feed additives, veterinary drugs and other fields, the enterprise adhering to provide customers with quality service, supply high-quality products, "world peace and health" as its responsibility, the company adhering to the "meet all customer requirements for products" as the service concept, Guarantee "provide qualified products" as the service principle, so that you get "God-like" noble shopping enjoyment. Our company has more than 1000 kinds of polypeptides, raw materials inventory, at any time to meet the various needs of customers for products. Is your best partner.
  • Inquiry History
    24 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Liraglutide

    1.00 KG Oct 8, 2024
    South Korea

    Liraglutide

    1 G Sep 19, 2026
    United Kingdom

    Liraglutide

    20 MG Jul 8, 2026
    United States

    MIC

    2 MT May 20, 2026
    United States

    Mic (Lipo C with B12), VIP, Ss31, glutathione and, Reta

    50 MG Mar 4, 2026
    Canada

    Liraglutide

    1 KG Dec 8, 2025
    United States

    liraglutide

    1 MT Nov 22, 2025
    Brazil

    Liraglutida

    1 G Sep 29, 2025
    United States

    Liraglutide

    1 KG Aug 13, 2025
    Sweden

    liraglutide

    1 KG Aug 4, 2025
    Pakistan

    liraglutide injection

    50 KG Jan 21, 2025
    India

    Liraglutide

    10 MG Jul 17, 2024
    India

    liraglutide

    1 KG Feb 25, 2026
    United States

    liraglutide

    1  Jan 21, 2026
    Reunion Island

    Liraglutide

    1 G Apr 14, 2025
    United States

    Liraglut

    1 MT Feb 9, 2025
    Israel

    Liraglutide

    1 G Aug 26, 2024
    India

    Liraglutide

    10 G Jun 26, 2024
    India

    Liraglutide

    100 G Mar 4, 2024
    United States

    Semaglutide Liraglutide powder

    10 G Feb 20, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.